Removal of Clinically Relevant SARS-CoV-2 Variants by An Affinity Resin Containing Galanthus nivalis Agglutinin
M. Gooldy, C. M. Roux, S. P. LaRosa, N. Spaulding, C. J. Fisher
This study evaluates the effectiveness of Galanthus nivalis agglutinin affinity resin in capturing clinically relevant SARS-CoV-2 variants, showing capture efficiencies between 53-89%.
bioRxiv · Apr 27, 2022Microbiology